NiKang Therapeutics Presents the Discovery and Unique Mechanism of Action of a Selective CDK2 Inhibitor NKT3447 at AACR Annual Meeting 2024 newsBy Elizabeth AspinallApril 5, 2024See the press release on Business Wire